After receiving approval for drug registration with the Department of Health, the medication will be delivered according to the MTP 3 form provided by the service facility. When the healthcare facility is about to run out of medication, they can request a new supply to prevent stock shortages. The Department of Health has established guidelines for healthcare facilities and providers for dispensing Mifepristone and Misoprostol packaged together as follows:
- Dispensing Mifepristone and Misoprostol will only be done in healthcare facilities that are adequately prepared, meaning they have a physician regularly on duty and can perform suction or curettage if medical abortion fails. They must also be able to provide blood transfusions or emergency life-saving measures if an emergency arises during the medical abortion process.
- The use and prescription of Mifepristone and Misoprostol must be conducted by a licensed physician who can accurately calculate gestational age and diagnose ectopic pregnancies. In cases of incomplete abortion or excessive bleeding, the physician must be able to perform suction or curettage or refer the patient to another adequately prepared healthcare facility. In cases where the patient may require a blood transfusion or emergency life-saving measures, the physician using Mifepristone and Misoprostol must ensure that the patient can access emergency services during the medical abortion process.
- The physician using Mifepristone and Misoprostol, or an assigned staff member, must explain the procedure and method of using the medication in detail to the patient choosing medical abortion and ensure that the patient fully understands.
- In cases where the patient cannot fully understand the procedure and method of using the medication, they should be scheduled to use Misoprostol at the healthcare facility under the supervision of medical personnel.